IRD

OPUS GENETICS INC

IRD·67577R102·US·Common Stock·Healthcare - Biotechnology-Activist

IRD (OPUS GENETICS INC) is held by 60 institutional investors as of Q2 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($24.8M), BlackRock, Inc. ($12.8M), BALYASNY ASSET MANAGEMENT L.P. ($12.7M). Net institutional sentiment: Bullish.

60
Holders
(4 Elite)
$123M
Total Value
75% (64)
Consensus
48 buying - 16 selling
13F: Insider & Congress: Updated regularly
IRD

Smart Money Verdict

View all
Loading verdict
Held by 60 funds
4 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jul 27, 2026 · Activists Aug 14, 2026 · Congress none

ActivistCACaligan Partners LP7.3%Aug 14, 2026
ActivistPAPerceptive Advisors LLC10.0%Aug 14, 2026
ActivistBALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.6.6%Aug 14, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
6M$24.8M0.0%-0.08%
0
Increased
3.1M(+2009.4%)$12.8M0.0%-4.99%
45
Increased
3.1M(+13.6%)$12.7M0.0%+72.05%
32
Increased
3M(+20.8%)$12.2M0.0%-10.08%
33
Decreased
2.3M(-12.5%)$9.5M0.0%+52.06%
0
Decreased
1.9M(-15.9%)$8M0.0%-7.17%
0
Increased
1.5M(+367.3%)$6.3M0.0%-8.21%
44
Increased
1.4M(+6.0%)$5.9M0.0%-10.42%
29
Increased
1.4M(+154.1%)$5.6M0.0%+6.85%
44
Increased
790,136(+295.2%)$3.2M0.0%+2.14%
43
Increased
683,895(+165.4%)$2.8M0.0%-1.55%
42
Increased
665,662(+450.6%)$2.7M0.0%+2.72%
42
Increased
464,900(+1076.3%)$1.9M0.0%-3.90%
42
Increased
442,154(+368.3%)$1.8M0.0%+2.49%
42
Increased
410,375(+45.6%)$1.7M0.0%-9.66%
35
New
371,950$1.5M0.0%-7.54%
35
New
330,783$1.4M0.0%-7.54%
35
Increased
253,962(+133.8%)$1M0.0%+24.80%
40
Decreased
196,897(-76.1%)$809,2470.0%+3.64%
0
Increased
188,988(+19.5%)$776,7410.0%-10.10%
29

Showing 1-20 of 69

1 / 4
IRDIRDOPUS GENETICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used